Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis

INTRODUCTION: Congenital heart disease (CHD) is one of the most prevalent birth defects in the world. The pathogenesis of CHD is complex and unclear. With the development of metabolomics technology, variations in metabolites may provide new clues about the causes of CHD and may serve as a biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xuelian, Li, Lu, Kang, Hong, Wang, Meixian, Zeng, Jing, Lei, Yanfang, Li, Nana, Yu, Ping, Li, Xiaohong, Liu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677635/
https://www.ncbi.nlm.nih.gov/pubmed/36404327
http://dx.doi.org/10.1186/s12872-022-02912-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677635/
https://www.ncbi.nlm.nih.gov/pubmed/36404327
http://dx.doi.org/10.1186/s12872-022-02912-2

Ejemplares similares